ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2025
Pediatric Antibiotic Stewardship Programs: The Path Forward.
Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic overuse has been well-documented in all populations, including pediatrics. Pediatric pharmacists are valuable and well-integrated within inpatient antibiotic stewardship programs (ASP) in children's hospitals. The Pediatric Pharmacy Association (PPA) believes all pharmacists, regardless of practice setting, should receive education to support entry-level stewardship activities in pediatric patients. Additionally, pediatric antibiotic stewardship pharmacist leaders should ideally be trained in both infectious diseases (ID) and pediatrics. Currently, specialized training in pediatric ID lacks standardization due to the paucity of subspecialized training opportunities. This paper provides recommendations to support pediatric ASP training, education, and pharmacist staffing for inpatient programs. Further, it is recommended to ensure protected time is available for daily and longitudinal pediatric ASP activities to support optimal care and prevent burnout. Finally, the PPA supports the evolving role of the pediatric pharmacist in the ambulatory ASP arena and recommends investigations into unique payment modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.